Nigerian faces more charges | Inquirer News

Nigerian faces more charges

By: - Senior Reporter / @inquirervisayas
/ 07:32 AM July 31, 2013

THE National Bureau of Investigation in Central Visayas (NBI-7) yesterday filed another complaint against the Nigerian businessman who was purportedly involved in illegal drug trade in Cebu.

James Cunta Okwudili Uyanneh is facing charges of illegal drug possession before the Cebu Provincial Prosecutors’ Office.

Charges for selling illegal drugs were earlier filed against Uyanneh before the Mandaue City Prosecutors’ Office.

Article continues after this advertisement

The additional complaint will undergo the regular preliminary investigation.

FEATURED STORIES

The prosecutor will give Uyanneh the chance to submit a counter-affidavit for him to refute the allegations.

In a July 18 raid, agents of the NBI-7 recovered 700 grams of shabu worth P3.5 million inside the rented apartment of Uyanneh in barangay Yati, Liloan, northern Cebu.

Article continues after this advertisement

Two days before his rented apartment was raided, the NBI-7 arrested Uyanneh after he sold 70 grams of shabu to two poseur-buyers for P350,000 inside Moonlight Lodging Inn in Mandaue City.

Article continues after this advertisement

The offense is non-bailable.

Uyanneh denied the allegations against him and accused the NBI-7 of setting him up./REPORTER ADOR VINCENT S. MAYOL

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.